Viewing Study NCT00758732

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-02-21 @ 6:24 AM
Study NCT ID: NCT00758732
Status: TERMINATED
Last Update Posted: 2015-09-28
First Post: 2008-09-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
Sponsor: Hellenic Oncology Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Ovarian cancer View
None Chemotherapy View
None Docetaxel View
None Carboplatin View
None Pegylated doxorubicin View
None Platinum sensitive View